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ABSTRACT
Correct functioning of the nervous system critically
depends on the formation of the precise neuronal
network. In mammals with binocular vision, axons of
retinal ganglion cells from the right and left eyes
project to different domains of the lateral geniculate
nucleus in the thalamus (Retinogeniculate
projection). This eye-specific visual projection
provides the anatomical basis for disparity-based
stereopsis (perception of depth). However, the
molecular mechanism that regulates the eyespecific visual projection is not well understood.
Nell2 (neural epidermal growth factor (EGF)-like-like
2) is an extracellular glycoprotein that is
predominantly expressed in the nervous system.
Our lab has previously shown that Nell2 acts as an
inhibitory axon guidance molecule in establishment
of the eye-specific retinogeniculate projection. The
current work aims to identify and functionally
characterize the receptor molecule that transduces
Nell2-mediated signaling in retinal ganglion cells. By
using immunohistochemistry, we found that the
receptor tyrosine kinase Ros1, which is known to
bind to Nell2, is expressed in developing chick
retinal ganglion cells, suggesting that Ros1 may act
as a receptor for Nell2 in the visual projection. We
are currently generating gene knock-down
constructs for Ros1, which will be used in in vitro
and in vivo axon guidance assays. We expect that
this project will elucidate the function of Nell2-Ros1
interaction in establishment of the eye-specific
retinogeniculate projection.

BACKGROUND

In vertebrates that have binocular vision, retinal
axons project to the both side of the brain.
Retinal axons from the ipsilateral (same side)
and the contralateral (opposite side) eyes
project to different layers/domains of the brain
target, the dorsal lateral geniculate nucleus
(dLGN) in the thalamus.

RESULTS

CONCLUSIONS
(A-C) Nell2 expression in the
developing dorsal lateral geniculate
nucleus (dLGN) was detected by RNA
in situ hybridization in postnatal day (P)
4-12 mice (purple). (D) Retinal axons
from the ipsilateral retina were labeled
with an axon tracer dye (white). Nell2
is expressed in the domain of the
dorsomedial dLGN where ipsilateral
axons terminate.

Retinal axons of the right and left eyes were labeled
at postnatal day (P) 9 by injection of cholera toxin B
(CTB)-Alexa Fluor 488 (green) and CTB-Alexa Fluor
594 (magenta), respectively. The left dorsal lateral
geniculate nucleus (dLGN) in coronal sections
prepared at P12 are shown. In wild type, ipsilateral
axons are confined to a single patch in the inner
region of the dLGN, and contralateral axons
terminate in the surrounding areas. In contrast, in
Nell2 null (Nell2-/-) mice contralateral axons invade
the ipsilateral area (asterisks), forming a mosaic
pattern of contralateral and ipsilateral axons. Dorsal
is at the top and lateral is on the left.
Explants of the ventrotemporal (containing
ipsilaterally projecting retinal ganglion cells
(RGCs)) (A,C) and ventronasal (containing
contralaterally projecting RGCs) (B,D)
retinae were prepared from day 15.5 mouse
embryos and cultured for 72 h on a
substratum coated with Nell2-AP (Fusion
protein of N ell2 with an alkaline
phosphatase tag) (A,B) or control AP
(unconjugated alkaline phosphatase) (C,D),
and axon outgrowth was quantified (E) (n=4
for each condition). Nell2-AP significantly
inhibited outgrowth of ventronasal retinal
axons.
Retinal sections were prepared
from chick embryos at embryonic
day (E) 9 and E14 and subjected
to immunohistochemistry using
anti-Ros1 and anti-Brn3a
antibodies. Ros1 expression was
detected in retinal ganglion cells
(RGCs) (at E9 and E14) and in
optic nerve fibers (ONFs) (at E14).
Brn-3a is a marker of RGCs. The
sections were counterstained with
hematoxylin. Scale bars, 50 μm.

Nell2 is expressed in the dorsomedial domain of the dorsal lateral
geniculate nucleus (dLGN), where ipsilateral axons terminate
(Ipsilateral domain). Ros1 is expressed in contralaterally projecting
retinal ganglion cells. The Nell2-Ros1 interaction mediates a
contralateral retinal axon-specific repulsion in the dLGN.
Contralateral RGC axons are repelled by Nell2, and thus they
avoid the ipsilateral domain and project to the surrounding
contralateral domain. In contrast, ipsilateral axons can project to
the ipsilateral domain. Ipsilateral axons do not terminate in the
contralateral domain because there is greater axon-axon
competition, thus they prefer to avoid this competition and arborize
only in the ipsilateral domain. In Nell2−/− mice, the Nell2-mediated
repulsion is removed, and contralateral axons can now invade the
ipsilateral domain and compete more effectively with ipsilateral
axons there. Subsets of the ipsilateral axons lose competition and
spread out into surrounding areas in the contralateral domain.

FUTURE DIRECTIONS
In future studies, we will investigate the function of Ros1 in the
eye-specific visual projection by using genetically modified mice in
which the Ros1 gene is deleted (Ros1 knockout mice) and in vitro
axon behavior assays. We will also study Ros1 functions in chick,
where the Nell2-Ros1 may be involved in the layer-specific visual
projection. We expect that our research will provide novel insights
into the molecular mechanisms for development of binocular vision
and neuronal network formation.
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